Sign In
to Vote &
Create Storyboards.
 
On February 25-26, the US Food and Drug Administration will hold a public meeting to discuss "oocyte modification in assisted reproduction for the prevention of transmission of mitochondrial disease." This will be the first public meeting ever held by the FDA to consider a form of human germline modification - inheritable genetic changes made to eggs, sperm or embryos.The technique (which has also been referred to as "mitochondrial manipulation," mitochondrial replacement" and "three-parent IVF"...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard